Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,835
Closed -$256K 808
2016
Q4
$256K Sell
6,835
-1,140
-14% -$41.5K 0.01% 626
2016
Q3
$293K Buy
+7,975
New +$268K 0.01% 581
2015
Q4
Sell
-7,576
Closed -$285K 686
2015
Q3
$285K Hold
7,576
0.01% 495
2015
Q2
$366K Sell
7,576
-217
-3% -$11.2K 0.01% 489
2015
Q1
$390K Buy
7,793
+172
+2% +$9.33K 0.01% 460
2014
Q4
$499K Sell
7,621
-629
-8% -$43.8K 0.01% 406
2014
Q3
$628K Buy
8,250
+82
+1% +$6.78K 0.01% 383
2014
Q2
$673K Buy
8,168
+531
+7% +$39.5K 0.01% 384
2014
Q1
$536K Sell
7,637
-6,052
-44% -$415K 0.01% 378
2013
Q4
$982K Buy
13,689
+7,165
+110% +$521K 0.02% 261
2013
Q3
$460K Hold
6,524
0.01% 345
2013
Q2
$405K Buy
+6,524
New +$402K 0.01% 306

Other funds holding NOV

Geneva Advisors's NOV Position: Q1 2017 in Review

Geneva Advisors sold out of NOV (NOV) in Q1 2017, closing a stake of 6,835 shares — an estimated $256K sold.

Geneva Advisors first reported a position in NOV in Q2 2013 and held it in 12 quarters. The position peaked at $982K in Q4 2013. 640 funds tracked by Wall St. Rank hold NOV as of Q1 2017.

  • Geneva Advisors reported no remaining NOV position as of Q1 2017 after selling out during the quarter.
  • Geneva Advisors sold 6,835 NOV shares in Q1 2017, an estimated $256K.
  • Geneva Advisors first reported a position in NOV in Q2 2013 and held it in 12 quarters.
  • Geneva Advisors's NOV position peaked at $982K in Q4 2013.
  • 640 funds tracked by Wall St. Rank held NOV as of Q1 2017.

Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.